Dr. Sandy Tretbar is a Molecular Biology and RNA Biochemist by training who spent her PhD and postdoc time in Germany and the US. After her second Postdoc in the immunology field, she joined the Fraunhofer IZI in 2018 as Research Associate and advanced as Group Leader in 2021. Now, she combines her long-standing RNA research experience with cell therapy development in immuno-oncology to investigate mRNA-based cell and gene therapies for the treatment of cancer and various other diseases.